Skip to main content
. 2024 May 29;23(2):1863–1870. doi: 10.1007/s40200-023-01370-7

Table 3.

Multivariable Multinomial Logistic Regression Model for 3, 6 and 9 years of follow-up by male and female: Tehran lipids and glucose study

Male Female
Regress to normal Progress to T2DM Regress to normal Progress to T2DM
RRR (95% CI) P-value RRR (95% CI) P-value RRR (95% CI) P-value RRR (95% CI) P-value
After 3 years
Model 1
Intervention 1.50 (1.10–2.04) 0.009 1.54 (1.04–2.27) 0.02 1.30 (1.00-1.69) 0.05 0.87 (0.61–1.23) 0.44
Model 2
Intervention 1.53 (1.11–2.10) 0.008 1.53 (1.02–2.31) 0.03 1.25 (0.95–1.64) 0.11 0.86 (0.60–1.24) 0.50
After 6 years
Model 1
Intervention 1.42 (0.99–2.02) 0.05 1.78 (1.19–2.65) 0.005 1.11 (0.83–1.49) 0.47 0.87 (0.62–1.22) 0.43
Model 2
Intervention 1.47 (1.02–2.12) 0.04 1.82 (1.20–2.76) 0.005 1.03 (0.75–1.40) 0.79 0.85 (0.60–1.21) 0.45
After 9 years
Model 1
Intervention 1.20 (0.76–1.88) 0.41 1.31 (0.83–2.07) 0.23 1.20 (0.76–1.88) 0.29 1.31 (0.83–2.07) 0.64
Model 2
Intervention 1.32 (0.83–2.10) 0.29 1.41 (0.88–2.26) 0.14 1.15 (0.78–1.70) 0.48 1.11 (0.75–1.65) 0.60

T2DM = Type 2 Diabetes; RRR = Relative Risk Ratio

Model 1 adjusted for age and model 2 further adjusted for all possible confounders measured at the baseline including BMI, systolic and diastolic blood pressure, FPG, 2 h-PG, HDL-C, TG, Education levels (≤ 6, 6–12 and > 12 years of education), Low physical activity (< 3 days of performing sports or heavy physical activity per week), current smoking, anti-hypertensive drug use, and Family history of T2DM